INTRODUCTION
Dysmenorrhea or painful menstruation is one of the most common gynecological problems [1] that involves about 50-70% of women during their reproductive life. [2] Its prevalence rate varies between 50% and 90% in different societies and in Iran was reported as many as 74-86.1%. [3] Primary dysmenorrhea is known as menstrual pain without pelvic disease, whereas secondary dysmenorrhea is associated with various pelvic causes. Primary dysmenorrhea usually occurs during 1-2 years after the menarche. [4] Although the etiology of primary dysmenorrhea is not completely known, it is introduced that prostaglandins (PGs) originating in secretory endometrium causes myometrial contractions. [5] The excessive or imbalanced prostanoids of endometer increases the dysrhythmic uterine contractions and basic muscle tone and active pressure that these conditions decrease the uterine blood flow and increase the sensitivity of peripheral nerves and cause Anethum graveolens (Dill), from Apiaceae family, is a traditional herb that has various medical indications worldwide. [17] It is cultivated in the most areas of the world and also widely in Khozestan, Khorasan, and Eastern Azerbaijan provinces of Iran. [18] It is a 1 year plant with 30-100 cm length. Its fruit essence consists of carveol, d-Carvone, d-hydrocarveol, dihydrocarvone, limonene, carvacrol thymol, etc. [19] its seeds have 3-3.5% essential oil and are used for treatment of stomach illnesses, food digestion, stopping hiccup, flowing of milk in nursing mothers, relieving of pain and as anticonvulsant and antivomiting. [18] We found no controlled research of effect of Dill in primary dysmenorrhea. The aim of this study was to investigate the effect of Dill seeds on pain severity of primary dysmenorrhea and to compare it with mefenamic acid and placebo.
MATERIALS AND METHODS
After initial approving by the vice chancellor for research of Qom University of Medical Sciences, complete explanations were given to the participants and informed consent form was taken. This double-blind, randomized study was conducted among 75 female students between 18 and 28 years old. Entry criteria were being single and educating in Nursing and Midwifery School and Paramedical Faculty of Qom University of Medical Sciences in 2011 (Qom city is almost situated in the center of Iran with about 150 km 2 distance from Tehran [metropolis of Iran]). In the beginning of the study, a complete history was taken and the secondary dysmenorrhea was ruled out. Patients with the history of pelvic or organic disorders, any known gastrointestinal or urogenital or hematological or other systems disorders, irregularity of menstrual cycles, taking any drug, and previous sensitivity to NSAIDs or Dill and or mild dysmenorrheal were not included.
The participants were allocated randomly into one of the following groups: In the first group, the patients were treated by Dill capsules containing 500 mg of powder of Dill seed in which two capsules orally q12h (totally 1000 mg q12h) and in the second group by 250 mg mefenamic acid capsule orally q12h and in the third group by starch as placebo (the same company) 500 mg q12h, since 2 days before the beginning of their menstruation for 5 days. All of the capsules were made by Boo Ali Research Center of Qom city and were completely similar in shape. In regarding the blinding process, the researchers and the participants were uninformed of allocating manner of each group and a third one that did not involve in analyzing and interpreting, etc., allocated the participants in groups and allotted a code number to everyone. The capsules were been delivered to the subjects 1-week before beginning the menstruation bleeding and during the study. The researchers were following the participants throughout the study in view of regular taking the capsules. The subjects were followed for two cycles (2 months) and were asked to answer to the questionnaires at the end of every cycle.
The participants filled a two part questionnaire at the beginning of study, including demographic characteristics in the first part (such as age, height, weight, etc.) and menstrual characteristics in the second part (such as menarche age, duration of menses, interval of cycles, etc.). [11] The severity of dysmenorrhea was assessed by a verbal multidimensional scoring (VMS) system and by a visual analog scale (VAS). VMS that has been used in various previous studies [11, 20] has four grades: Grade 0: Menstruation with no influence on daily activities or use of analgesics Grade 1: Menstruation with mild pain but rare influence on daily activities or use of analgesics Grade 2: Menstruation with moderate pain with influence on daily activities and perpetuity need to analgesics, Grade 3: Menstruation with severe pain with significant limitations on daily activities and ineffective use of analgesics and vegetative symptoms as headache, nausea, vomiting, tiredness, and diarrhea. [11, 20] According to the 10-point VAS, mild dysmenorrhea was defined as score of 0-3, moderate as score of 4-7 and severe as score of 8-10. [21] Women with mild dysmenorrhea (score of 0-3) were excluded from this study. [11] They also answered to the questionnaires at the end of the first and the 2 nd months of treatment. These questionnaires had questions about changes of the menstrual cycle due to taking capsules or special events, etc.
Of 75 participants of this study, five of them did not continue the study due to fearing of its side-effects; therefore we evaluated 70 students [ Figure 1 ]. Data are presented as . P < 0.05 was considered to be statistically significant.
Ethical considerations
The vice chancellor of Qom University of Medical Sciences approved the study. At beginning, complete information about this study was given to the participants then informed consents of randomized-controlled trial studies were taken from them. Students were ensured of being secret their answers. This research project is registered in IRCT with No. 201110205543N2.
RESULTS
Of 75 participants of this study, five of them did not continue the study; therefore finally, seventy students were analyzed: 23 students in Dill group, 23 in the placebo group and 24 in mefenamic acid group.
The mean age of the participants was 21.32 ± 2.3 years (ranging between 19 and 23 years). Characteristics of students are shown in Table 1 . There was no significant difference between three groups for demographic or descriptive variables. Comparison of pain severity in the three groups before and after treatment showed that before treatment, 2.9% of participants of Group 1 (Dill) and 7.1% of Group 2 (mefenamic acid) were complaint of menstruation with severe pain with significant limitations on daily activities that was not responding to analgesics, but after treatment, this rate reached to 1.4% and 0%, respectively in this two groups [ Table 2 ].
In comparison of VAS, before and after treatment, pairedsample t-test showed that in Group 1 (Dill), the subjects had lower significant pain in the 1 st and the 2 nd months after treatment than before it (P < 0.0001). In Group 2 (mefenamic acid), also Wilcoxon signed-rank test showed that also participants had lower significant pain in the first (P = 0.001) and the 2 nd months (P < 0.0001) than before treatment. In Group 3 (placebo) paired-sample t-test showed that this difference was nonsignificant in the 1 st month (P = 0.05), but it was significant in the 2 nd month than before treating (P = 0.001). In comparison of effect of Dill and mefenamic acid on decreasing the severity of primary dysmenorrhea, Mann-Whitney test showed no significant difference in the 1 st and 2 nd months after treatment (P > 0.05) [ Table 3 ].
In assessing the side-effects, in Dill group, two students reported menstrual changes as increasing in amount and duration of bleeding and one student reported gastrointestinal discomfort. In mefenamic acid group, menstrual changes and gastrointestinal discomfort were reported in one and two students, respectively. In placebo group, each of the mentioned side-effects was only observed in one student. These differences between three groups were statistically nonsignificant (P = 0.621).
DISCUSSION
In this double-blind randomized study, it was demonstrated that Dill can be as effective as mefenamic acid in decreasing the pain severity of primary dysmenorrhea. The results are in agreement with the results of Mohammadinia et al. [22] Furthermore, Our findings are similar to those of Gharib Naseri et al. that investigated the effects of 0.5, 1, 2, 4, and 8 mg/kg of Dill fruit hydroalcoholic extract (DFHE) on virgin rat uterus contractions induced by KCl (60 mM) and oxytocin (10 mU/m1). [19] In their study, in the presence of calcium, DFHE increased contractions, but in the absence of calcium, the contractions induced by oxytocin was weaker than KCL. Furthermore, Garib Naseri and Heidari explored the effects of 0.5, 1, 2, and 4 mg DFHE on rat ileum contractions and found that DFHE has dosedependently spasmolytic effect on the KCl-, acetylcholine and BaCl 2 -induced contractions of ileum. [23] Also, our study results are in agreement with those of Iravani that found that branches of thyme such as Dill can decrease the severity of dysmenorrhea due to having tannin. [24] One of the main mechanisms of dysmenorrhea is increasing the production of PGs (mainly PGF2α) in the endometrium that resulted in myometrial contractions and primary dysmenorrhea. [5, 11] Anti-PGs such as NSAIDs can inhibit cyclooxygenase two and therefore PGs synthesis and relieve primary dysmenorrhea pain. [11, 25] According to the conducted studies, Dill seeds have two main compounds include tannin and anethol that have sedative effects while increase the uterus contractions during and after child-bearing. [26] [27] [28] Anethol that is the main compound of essential oils of many herbal plants is used in the curing of anxiety, gastrointestinal comforts, and different pains. [28] Anethol in low dose, causes vasospasm through opening the voltage-dependent calcium channels but in high dose, relaxes the blood vessels. [29] Gharib Naseri et al. believe that the relaxant effect of Dill on uterus contractions is due to closing the voltage-dependent calcium channels and also, indirectly, due to calcium-releasing disorders from intracellular pool. [19] it is suggested that αand B-adrenoceptors, opioid receptors and no production are not involved in this inhibitory effect of DFHE on contractions. [23] However, our findings do not support those of some studies. [26, 30, 31] Ishikawa et al. and Mahdavian et al. found that aqueous extract of Dill fruit decreases postpartum hemorrhage through increasing the uterus contractions. [26, 30] Furthermore, Mansouri et al. found that the extract of Dill fruit induces the labor pains. [31] one possible explanation for these discrepancy is that the current study is done on nonpregnant uterus. Another possibility is that the compositions of seed and fruit of Dill are different. Hence, the accurate determination of the mechanisms needs to separate the constituent elements.
In view of side-effects, menstrual changes as increasing in amount and duration of bleeding and gastrointestinal discomfort were nonsignificantly reported in Dill group. Mohammadinia et al. also in comparing the effect of Anethum gravolens with mefenamic acid consumption on treatment of primary dysmenorrhea in students of Iranshahr reported nausea and dizziness in 6 students that were taken Dill. [22] Mahdavian et al. (2001) in an investigation of effectiveness of oral Dill extracts on postpartum hemorrhage reported no side-effects in Dill recipients. [26] We did not explore in this study the interactivity of Dill capsules with other drugs especially with NSAIDs and also its effects on other signs and symptoms of primary dysmenorrhea, so further research is recommended to assess them. Furthermore, because of all the participants were single, we did no pelvic examination for rule out organic pelvic disease and secondary dysmenorrhea. Hence, we were contented only to their history (age of beginning dysmenorrhea, history of lack of related disease, etc.).
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